Verici Dx Plc (VRCI) ORD GBP0.001
0.25p
(22.22%)
- Add to watchlist
- Create an alert
- This stock can be held in a
0.25p
(22.22%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
0.25p
(22.22%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
1.13p
1.25p
8.25p
£2.12 million
1.13p
0.78p
0.88p
n/a
0.00p (0.00%) Previous:
0.00p
980,154
n/a
50,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2024 | 31/12/2023 |
|---|---|---|
| Revenue ($m) | 3.34 | 1.01 |
| Profit before tax ($m) | (5.87) | (8.73) |
| Adjusted EPS (¢): | (2.50) | (5.10) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: US dollar
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Verici Dx reports record Tutivia orders, downgrades revenue outlook
7 April 2025 11:26
-
Verici Dx announces delay to Medicare determination for Tutivia test
11 October 2024 11:50
-
Verici Dx reaches Thermo Fisher collaboration milestone
1 July 2024 13:34
-
Final Results
30 June 2025 07:00
-
Update on funding to accelerate commercial growth
11 June 2025 07:00
-
Result of General Meeting
27 May 2025 14:42
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.